Maxcyte (MXCT) Interest & Investment Income (2020 - 2026)

Maxcyte (MXCT) has reported Interest & Investment Income for 7 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 27.38% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $6.2 million, a 29.27% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, down 28.35% from the prior year.
• Interest & Investment Income was $1.4 million for Q2 2026 at Maxcyte, down from $1.4 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.8 million in Q4 2023 and troughed at $91800.0 in Q1 2022.
• A 5-year average of $1.9 million and a median of $2.0 million in 2022 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income jumped 5466.28% in 2022 and slumped 30.57% in 2025, its largest moves.
• Over 5 years, Interest & Investment Income stood at $2.0 million in 2022, then surged by 44.36% to $2.8 million in 2023, then dropped by 18.24% to $2.3 million in 2024, then decreased by 29.25% to $1.6 million in 2025, then dropped by 16.69% to $1.4 million in 2026.
• The last three Interest & Investment Income figures came in at $1.4 million (Q2 2026), $1.4 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.